Skip to content
AnalystLens
Back to VRTXIncome Statement

VERTEX PHARMACEUTICALS INC / MA Net Income 2008-2026 | VRTX

Annual FY2008–FY2025 · quarterly through Q1 FY2026

Latest annual · FY2025

$3.95B

+838.1%YoY vs FY2024Source: 10-KFY2025

From −$459.9M in FY2008 to $3.95B in FY2025.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$1.0B+59.6%Not reportedNot reportedNot reported
FY25$646M−41.2%$1.0B+128.7%$1.1B+3.6%$1.2B+30.5%
FY24$1.1B+57.1%−$3.6B−492.4%$1.0B+1.0%$913M−5.8%
FY23$700M−8.2%$916M+13.0%$1.0B+11.3%$969M+18.3%
FY22$762M+16.7%$811M+1109.7%$931M+9.2%$819M+6.3%
Share22%22%25%31%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date. Share: its typical part of the fiscal year.

Key Statistics

Trend DirectionStable
CAGR

+7.8%

FY2020
$2.71B
FY2025
$3.95B

5 years selected · on the chart

01—History

Net Income History

Year-over-year comparison from 10-K annual reports

  18. $3.95B
YoY changeLargest recent move+695.8%in FY18Latest +838.1%

5 older moves run past ±150% (largest +838.1%); point at, tap or drag across the bars to read one.

02—Ledger

Net Income, period by period

PeriodValueChangeSource
FY2025$3.95B+838.1%10-K
FY2024−$535.6M−114.8%10-K
FY2023$3.62B+9.0%10-K
FY2022$3.32B+41.8%10-K
FY2021$2.34B−13.6%10-K
FY2020$2.71B+130.4%10-K
FY2019$1.18B−43.9%10-K
FY2018$2.10B+695.8%10-K
FY2017$263.5M+335.1%10-K
FY2016−$112.1M+79.9%10-K
FY2015−$556.3M+24.7%10-K
FY2014−$738.6M−66.0%10-K
FY2013−$445.0M−315.8%10-K
FY2012−$107.0M−461.9%10-K
FY2011$29.6M+103.9%10-K
FY2010−$754.6M−17.5%10-K
FY2009−$642.2M−39.6%10-K
FY2008−$459.9M—10-K

03—Questions

What is net income?

Net income can be defined as the company's total earnings or profit. It is calculated as revenues minus all expenses including cost of goods sold, operating expenses, interest, and taxes.

What is VERTEX PHARMACEUTICALS INC / MA's current net income?

VERTEX PHARMACEUTICALS INC / MA (VRTX) annual net income for 2025 was $3.95B, a 838.09% increase from 2024. VERTEX PHARMACEUTICALS INC / MA net income for the quarter ending March 31, 2026 was $1.03B.

What was VERTEX PHARMACEUTICALS INC / MA's net income in 2024?

VERTEX PHARMACEUTICALS INC / MA annual net income for 2024 was $-535.6M, a 114.80% decline from 2023.

What was VERTEX PHARMACEUTICALS INC / MA's net income in 2023?

VERTEX PHARMACEUTICALS INC / MA annual net income for 2023 was $3.62B, a 8.96% increase from 2022.

What is VERTEX PHARMACEUTICALS INC / MA's 5-year net income CAGR?

VERTEX PHARMACEUTICALS INC / MA net income grew at a compound annual growth rate (CAGR) of 7.83% from FY2020 to FY2025, going from $2.71B to $3.95B over 5 years.

Company
VERTEX PHARMACEUTICALS INC / MA
Ticker
VRTX
Sector
Healthcare
Industry
Pharmaceutical Preparations
View company profile →